尼帕尔4是清细胞细胞癌预后和免疫治疗的重要标志物

Shuyan Wei1,2, Fang Lyu3, Bei Qian4

  • 1Department of Traditional Chinese Medicine and Acupuncture, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, 442000, P.R. China.

Scientific reports
|March 27, 2025
PubMed
概括

载体NIPAL4的高表达表明清细胞细胞癌 (ccRCC) 患者的预后不佳. NIPAL4可以作为ccRCC的治疗标和免疫治疗标记物.